Gene · 28935
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A prospective cohort study on serum A20 as a prognostic biomarker of aneurysmal subarachnoid hemorrhage. | World J Emerg Med | 2023 | 37908792 | PubTator, text mining | PubMed |
| Acquired resistance to crizotinib in novel CDK14-ALK and CLTC-ALK fusions of ALK-positive large B-cell lymphoma identified by next-generation sequencing. | Cancer Biol Ther | 2023 | 37906510 | PubTator, text mining | PubMed |
| A non-small cell lung carcinoma patient responded to crizotinib therapy after alectinib-induced interstitial lung disease. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37899398 | PubTator, text mining | PubMed |
| Vulnerability in adolescents' daily life during the COVID-19 pandemic. | Rev Esc Enferm USP | 2023 | 37882696 | PubTator, text mining | PubMed |
| A20 regulates lymphocyte adhesion in murine neuroinflammation by restricting endothelial ICOSL expression in the CNS. | J Clin Invest | 2023 | 37856217 | PubTator, text mining | PubMed |
| Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual. | iScience | 2023 | 37841584 | PubTator, text mining | PubMed |
| A computational model of the DNA damage-induced IKK/ NF-κB pathway reveals a critical dependence on irradiation dose and PARP-1. | iScience | 2023 | 37817938 | PubTator, text mining | PubMed |
| Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients. | J Clin Virol | 2023 | 37778220 | PubTator, text mining | PubMed |
| Soft-capsule formulation of a re-esterified triglyceride omega-3 employing self-emulsifying technology and bioavailability evaluation in healthy volunteers. | Heliyon | 2023 | 37767491 | PubTator, text mining | PubMed |
| E3 Ubiquitin Ligases in Gammaherpesviruses and HIV: A Review of Virus Adaptation and Exploitation. | Viruses | 2023 | 37766341 | PubTator, text mining | PubMed |
| Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report. | J Am Heart Assoc | 2023 | 37750583 | PubTator, text mining | PubMed |
| Genetic tracing of market wildlife and viruses at the epicenter of the COVID-19 pandemic. | bioRxiv | 2023 | 37745602 | PubTator, text mining | PubMed |
| Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus. | Front Immunol | 2023 | 37736101 | PubTator, text mining | PubMed |
| Regulatory effect of zinc finger protein A20 on rheumatoid arthritis through NLRP3/Caspase-1 signaling axis mediating pyroptosis of HFLS- RA cells. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37715399 | PubTator, text mining | PubMed |
| A cutting-edge strategy for spinal cord injury treatment: resident cellular transdifferentiation. | Front Cell Neurosci | 2023 | 37711511 | PubTator, text mining | PubMed |
| Emissions from modern engines induce distinct effects in human olfactory mucosa cells, depending on fuel and aftertreatment. | Sci Total Environ | 2023 | 37709087 | PubTator, text mining | PubMed |
| The Regulation of Ferroptosis by Noncoding RNAs. | Int J Mol Sci | 2023 | 37686142 | PubTator, text mining | PubMed |
| Structural analysis of peptide binding to integrins for cancer detection and treatment. | Biophys Rev | 2023 | 37681100 | PubTator, text mining | PubMed |
| Post-COVID symptoms are associated with endotypes reflecting poor inflammatory and hemostatic modulation. | Front Immunol | 2023 | 37680625 | PubTator, text mining | PubMed |
| Advances in post-translational modifications of proteins and cancer immunotherapy. | Front Immunol | 2023 | 37675097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28935/papers?page=9